scispace - formally typeset
S

Salwa Kamourieh

Researcher at Imperial College London

Publications -  8
Citations -  743

Salwa Kamourieh is an academic researcher from Imperial College London. The author has contributed to research in topics: Internal medicine & Tolerability. The author has an hindex of 4, co-authored 6 publications receiving 663 citations. Previous affiliations of Salwa Kamourieh include Imperial College Healthcare.

Papers
More filters
Journal ArticleDOI

Fractionating the Default Mode Network: Distinct Contributions of the Ventral and Dorsal Posterior Cingulate Cortex to Cognitive Control

TL;DR: Results provide evidence that the posterior cingulate cortex is involved in supporting internally directed thought, as the region is more highly integrated with the DMN at low task demands.
Journal ArticleDOI

MR volume of the fetal cerebellum in relation to growth

TL;DR: To quantify fetal cerebellar growth by measuring Cerebellar volumes of normal fetuses throughout gestation with MRI with MRI.
Journal ArticleDOI

Neural Systems Involved When Attending to a Speaker

TL;DR: It is shown that domain-general frontoparietal systems, where activity increased during attentive listening but was modulated little by the need for speech stream segregation in the presence of 2 speakers, include a ventral right frontopARietal system and other domain- general frontoprietal systems where activity was dependent on both the task demand and the Presence of a competing speaker.
Journal ArticleDOI

Non-invasive vagus nerve stimulation is beneficial in chronic paroxysmal hemicrania

TL;DR: A recent audit looking at 15 patients with indomethacin-responsive headaches concluded that nVNS may be an important adjunct or alternative in those patients with …
Journal ArticleDOI

Natalizumab granule cell neuronopathy: FDG-PET in diagnosis and immune reconstitution with G-CSF.

TL;DR: Granule cell neuronopathy (GCN) is a rare presentation of JC virus infection targeting the cerebellum and granulocyte-colony stimulating factor (G-CSF) has emerged as a potential treatment.